117 related articles for article (PubMed ID: 7808803)
1. Ag-NOR counting for differentiation of follicular thyroid tumours.
Cör A; Pajer Z
Pathologica; 1994 Jun; 86(3):301-3. PubMed ID: 7808803
[TBL] [Abstract][Full Text] [Related]
2. Measurement characteristics of stereological and histochemical methods in the diagnosis of thyroid tumours.
Cör A; Pajer Z
Oncology; 1994; 51(5):426-9. PubMed ID: 8052483
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the nucleolar organizer regions (NORs) in the thyroid follicular tumours. Comparison of the cytological and histopathological examinations.
Musiatowicz B; Dziecioł J; Augustynowicz A; Miller-Famulska D; Sulik M; Famulski W; Chabowski A; Jabłońska E; Andrzejewicz A; Mielech W; Guzińska-Ostymowicz K
Rocz Akad Med Bialymst; 1998; 43():186-93. PubMed ID: 9972054
[TBL] [Abstract][Full Text] [Related]
4. Morphometric parameters and silver stain used in diagnosis of thyroid follicular diseases.
Ciobanu D; Căruntu ID; Vulpoi C; Florea N; Giuşcă SE
Rom J Morphol Embryol; 2006; 47(4):323-30. PubMed ID: 17392977
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of MIB-1 immunoreactivity and nucleolar organizer regions in nonneoplastic and neoplastic thyroid lesions.
Lewy-Trenda I; Bieńkiewicz M
Pol J Pathol; 1999; 50(3):129-38. PubMed ID: 10624114
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 and AgNOR proliferative markers as diagnostic adjuncts to fine needle aspiration cytology of thyroid follicular lesions.
Mehrotra A; Goel MM; Singh K
Anal Quant Cytol Histol; 2002 Aug; 24(4):205-11. PubMed ID: 12199321
[TBL] [Abstract][Full Text] [Related]
7. Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid.
Cho Mar K; Eimoto T; Nagaya S; Tateyama H
Histopathology; 2006 Jun; 48(7):801-7. PubMed ID: 16722928
[TBL] [Abstract][Full Text] [Related]
8. Comparison of metallothionein (MT) and Ki-67 antigen expression in benign and malignant thyroid tumours.
Królicka A; Kobierzycki C; Puła B; Podhorska-Okołów M; Piotrowska A; Rzeszutko M; Rzeszutko W; Rabczyński J; Domosławski P; Wojtczak B; Dawiskiba J; Dzięgiel P
Anticancer Res; 2010 Dec; 30(12):4945-9. PubMed ID: 21187474
[TBL] [Abstract][Full Text] [Related]
9. Nucleolar organizer regions in follicular tumors of the thyroid.
Shem-Tov Y; Straus M; Talmi YP; Rath-Wolfsom L; Zohar Y; Gal R
Head Neck; 1994; 16(5):420-3. PubMed ID: 7525511
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
[TBL] [Abstract][Full Text] [Related]
11. [Galectin-3 in differential diagnosis and prognosis of follicular tumors of the thyroid gland].
Iushkov PV; Antonova SS; Bartolazzi A
Arkh Patol; 2004; 66(6):39-42. PubMed ID: 15648166
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
13. Significance of AgNORs and ki-67 proliferative markers in differential diagnosis of thyroid lesions.
Aiad HA; Bashandy MA; Abdou AG; Zahran AA
Pathol Oncol Res; 2013 Apr; 19(2):167-75. PubMed ID: 23055017
[TBL] [Abstract][Full Text] [Related]
14. Morphometric study by image analysis of Ag-stained nucleoli in thyroids bearing proliferating lesions.
Abdo-Banhos CR; Cordeiro JA; Rosa CS; Bicudo HE
J Submicrosc Cytol Pathol; 2004 Jan; 36(1):37-43. PubMed ID: 15311673
[TBL] [Abstract][Full Text] [Related]
15. [Significance of argyrophilic proteins of the nucleolar organizer region in differentiation of benign and malignant growth of thyroid epithelial tumors].
Bukaeva IA; Smirnova EA; Pavlovskaia AI; Makanin MA; Ol'khovskaia IG; Raĭkhlin NT
Arkh Patol; 2001; 63(3):15-8. PubMed ID: 11452646
[TBL] [Abstract][Full Text] [Related]
16. AgNOR quantification in the diagnosis of follicular pattern thyroid lesions.
Słowińska-Klencka D; Klencki M; Popowicz B; Lewiński A
Anal Quant Cytol Histol; 2003 Dec; 25(6):347-52. PubMed ID: 14714301
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic applicability of dipeptidyl aminopeptidase IV activity in cytological samples for differentiating follicular thyroid carcinoma from follicular adenoma.
Maruta J; Hashimoto H; Yamashita H; Yamashita H; Noguchi S
Arch Surg; 2004 Jan; 139(1):83-8. PubMed ID: 14718282
[TBL] [Abstract][Full Text] [Related]
18. Macrofollicular variant of follicular thyroid carcinoma: a clinical, cytologic, morphologic, and image analysis study of a unique case.
Bongiovanni M; Gremaud M; Moulin CS; Scheidegger C; Biton C; Clément S
Ann Diagn Pathol; 2009 Apr; 13(2):101-5. PubMed ID: 19302958
[TBL] [Abstract][Full Text] [Related]
19. Argyrophilic nucleolar organizing region associated protein synthesis for cytologic discrimination of follicular thyroid lesions.
Oktay M; Eroz R; Oktay NA; Erdem H; Başar F; Akyol L; Cucer N; Bahadir A
Biotech Histochem; 2015 Apr; 90(3):179-83. PubMed ID: 25420891
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 expression in follicular tumours: an immunohistochemical study of its use as a marker of follicular carcinoma.
Ito Y; Yoshida H; Tomoda C; Miya A; Kobayashi K; Matsuzuka F; Yasuoka H; Kakudo K; Inohara H; Kuma K; Miyauchi A
Pathology; 2005 Aug; 37(4):296-8. PubMed ID: 16194828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
